TGF-beta plays an important role in lung fibrosis, which is a major cause o
f suffering and death seen in pulmonary disease. Smad7 has been recently id
entified as an antagonist of TGF-beta signaling. To investigate whether thi
s novel molecule can be exploited for therapy of lung fibrosis, we determin
ed the effect of exogenous Smad7, introduced by a recombinant human type 5
adenovirus vector, on bleomycin-induced lung fibrosis in mice. C57BL/6 mice
with bleomycin-induced lungs received an intratracheal injection of a reco
mbinant adenovirus carrying mice Smad7 cDNA. These mice demonstrated suppre
ssion of type I precollagen mRNA, reduced hydroxyproline content, and no mo
rphological fibrotic responses in the lungs when compared with mice adminis
tered adenovirus carrying Smad6 cDNA. In addition, we found that expression
of Smad7 transgene blocked Smad2 phosphorylation induced by bleomycin in m
ouse lungs. These data indicated that gene transfer of Smad7 (but not Smad6
) prevented bleomycin-induced lung fibrosis, suggesting that Smad7 may have
applicability in the treatment of pulmonary fibrosis.